T&R Biofab Revenue

T&R Biofab had revenue of 9.54B KRW in the quarter ending June 30, 2026, with 45.88% growth. This brings the company's total for the last twelve months to 32.73B, up 120.91% year-over-year. In the year 2025, T&R Biofab had annual revenue of 26.97B with 453.32% growth. That makes T&R Biofab the 32,539th largest company in the world by revenue and 2,074th in South Korea.

Revenue (ttm)

32.73B

Revenue Growth

+120.91%

P/S Ratio

2.80

Revenue / Employee

380.61M

Employees

Market Cap

91.75B

Revenue Chart

Chart

Revenue by Segment

By Segment

Chart

Cosmetics and Container Division 19.54B 72.0%
Biomedical Engineering Devices Division 7.58B 28.0%

By Geography

Chart

South Korea 24.12B 89.4%
USA 1.21B 4.5%
China 630.25M 2.3%
Hong Kong 346.32M 1.3%
Australia 205.42M 0.8%
Philippines 127.94M 0.5%
Malaysia 114.19M 0.4%
Other 213.66M 0.8%

Fiscal year ended Dec 31, 2025 See the full T&R Biofab breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	26.97B	22.09B	453.32%
Dec 31, 2024	4.87B	-325.47M	-6.26%
Dec 31, 2023	5.20B	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.